A Glimpse At Global Medtech Markets: China

Posted by Life Science Intelligence on Aug 23, 2019 6:39:20 AM
Find me on:

In the last year, the stability of the US relationship with China has changed. From the implementation of new tariffs to back-and-forth threats of a full-on trade war, both countries have started to pull back on shared interests and forward pursuit.

It wasn’t too long ago that much of China’s medical community preferred and purchased devices that were developed in the west. Practitioners, many of whom had an education in Western-based medicine, would focus on these products rather than on development at home.

All that changed as medtech companies within China started producing new innovations, often at lower prices than their Western counterparts. Added to China’s nationalism, it became more lucrative for insurance, providers, patients, and manufacturers to buy local. And since that change of focus, China has surged to a significant role in the global medtech industry. 

Shanghai, China cityscape overlooking the Financial District and Huangpu River.

In particular, China has been the center of the development of artificial intelligence that has demonstrably effective results in the medical industry. This past July, the Chinese government hosted a conference in Beijing to show a further commitment to growth and innovation. In order to provide greater outreach to the population, the national administration announced a partnership with hospitals and organizations throughout the country. 

China’s medical products administration also launched a pilot program this summer to start implementing unique device identification. The first phase of the program will look at tracking high-risk implants. The focus for investors and manufacturers, of course, is whether or not this new system will work with that of the FDA and with upcoming changes to the EU.

As China’s medtech industry continues to advance forward, more processes and products will be brought to market with a built-in global reach.



Topics: Medtech

Stay connected with our latest posts:

About the Author

Life Science Intelligence (LSI) helps medtech executives make better strategic decisions by delivering unique market data and business insights. For over 13 years LSI has been working with industry giants – Johnson & Johnson, Medtronic, Abbott, Stryker, Cardinal, Boston Scientific, and Becton Dickinson, among others. LSI products are also leveraged by the most successful start-ups, innovators, investors, and service companies that compete in medtech. LSI is the organizer of The Emerging Medtech Summit held annually in Southern California.

Contact LSI here, via phone 714 847 3540, or email info@lsintel.com